Myco-mediated synthesis of molybdenum oxide nanoparticles using Fusarium sp. strain JK-2 and their anticancer and antibacterial applications
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05144-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Bhuvaneshwar Ramalingam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Genetic Engineering, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. Hauptthemen laut MEDLINE: Molybdenum, Fusarium, Anti-Bacterial Agents, Oxides. Die Arbeit nennt 82 Literaturangaben. Gefördert von: Tamil Nadu State Council for Higher Education.
Abstract (Originalsprache)
Oral cancer is among the six most prevalent cancers globally, with conventional treatments such as chemotherapy and radiotherapy limited by systemic toxicity, drug resistance and poor selectivity. Although molybdenum trioxide nanoparticles (MoO3NPs) have shown promising biomedical applications, studies on myco-mediated MoO3NP synthesis and their specific relevance to oral cancer therapy remains limited, highlighting an important knowledge gap. In this study, we report the first myco-fabrication of Fu@MoO3NPs using an endophytic fungus, Fusarium sp. strain JK-2, isolated from Justicia tranquebariensis Linn, selected for its rich secondary metabolite profile and strong reducing and stabilizing capability. GC-MS analysis of fungal extract revealed 20 bioactive compounds, supporting its role in eco-friendly nanoparticle synthesis. The synthesized Fu@MoO3NPs were extensively characterized and exhibited a characteristic UV Vis absorption peak at 340 nm, confirming the SPR characteristic of MoO3NPs. The TEM micrographs confirm the quasi-spherical-shaped Fu@MoO3NPs with an average size of 10.39 ± 1.62 nm. The Fu@MoO3NPs showed effective antibacterial activity against methicillin-resistant Staphylococcus aureus MTCC 1430 (MRSA) (MIC: 100 µg/mL) and showed excellent biocompatibility against normal 3T3-mouse fibroblast cells. Furthermore, cytotoxicity studies demonstrated that Fu@MoO3NPs induce dose-dependent apoptosis, cause cell cycle arrest at the G0/G1 phase, and inhibit the migration, highlighting their relevance to oral cancer. These results confirm the dual antibacterial and anticancer potential of myco-synthesized Fu@MoO3NPs, suggesting their promise as multifunctional candidates for translational medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Genetic Engineering, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
- Department of Biotechnology and Genetic Engineering, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. sivaramakrishnan123@gmail.com.
Förderung
- Tamil Nadu State Council for Higher Education
Zitieren
APA
Ramalingam, B., Dhanaraju, M., & Sivaperumal, S. (2026). Myco-mediated synthesis of molybdenum oxide nanoparticles using Fusarium sp. strain JK-2 and their anticancer and antibacterial applications. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05144-9
Vancouver
Ramalingam B, Dhanaraju M, Sivaperumal S. Myco-mediated synthesis of molybdenum oxide nanoparticles using Fusarium sp. strain JK-2 and their anticancer and antibacterial applications. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05144-9
BibTeX
@article{Ramalingam2026,
author = {Ramalingam, Bhuvaneshwar and Dhanaraju, Malini and Sivaperumal, Sivaramakrishnan},
title = {Myco-mediated synthesis of molybdenum oxide nanoparticles using Fusarium sp. strain JK-2 and their anticancer and antibacterial applications},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05144-9}
}
EUVIMED